TXMD
TherapeuticsMD, Inc. Common Stock
Drug Manufacturers - Specialty & Generic · Healthcare · United States
1.83
close · 2026-10-29
value
68
cheaper than peers68
quality
36
stronger fundamentals36
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 0.78× | 93 |
| forward P/E | 5.23× | 86 |
| price to sales | 7.29× | 12 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 20.5% | 81 |
| return on equity | -1.1% | 60 |
| revenue growth | -8.7% | 20 |
| operating margin | -32.2% | 19 |
4 of 4 measures available
Facts
| market cap | $21M |
| free cash flow | $896,625 |
| employees | 1 |
| first trade | 2007-05-09 |
| next earnings | not reported |
| fundamentals updated | 2026-08-20 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.05 | -0.19 | -0.98 | 11.96 |
| free cash flow | $2.5M | $1.2M | -$23.1M | $9.0M |
| net income | -$569,000 | -$2.2M | -$10.3M | $112.0M |
| revenue | $3.0M | $1.8M | $1.3M | $70.0M |
| unusual items | -$176,000 | -$1.3M | $0 | -$9.5M |